id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-E-0113-0007,FDA,FDA-2011-E-0113,FDA\CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T20:10:42Z,,0,0,090000648119cadd
FDA-2011-E-0113-0006,FDA,FDA-2011-E-0113,Regulatory Review Period for Purposes of Patent Extension: GILENYA,Notice,General Notice,2012-05-04T04:00:00Z,2012,5,2012-05-04T04:00:00Z,2012-07-04T03:59:59Z,2012-05-04T13:51:30Z,2012-10819,0,0,0900006481005048
FDA-2011-E-0113-0005,FDA,FDA-2011-E-0113,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-04-18T04:00:00Z,2012,4,2012-04-18T04:00:00Z,,2012-04-18T13:35:47Z,,0,0,0900006480ff33a3
FDA-2011-E-0113-0004,FDA,FDA-2011-E-0113,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,Letter(s),2012-01-10T05:00:00Z,2012,1,2012-01-10T05:00:00Z,,2012-01-10T14:43:49Z,,0,0,0900006480f91f0f